Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention(...)
lung cancer
Cancer Matters with Dr. Bill Nelson – New Treatment Options for Lung Cancer
Posted by | podcastIn our next podcast, Dr Bill Nelson talks with Dr Ben Levy, the Clinical Director of Medical Oncology at Sibley Memorial Hospital, Johns Hopkins Medicine, about new treatments for lung cancer patients and the growing cancer center at Sibley. In this preview, Dr Nelson and Dr Levy discuss how immunotherapy drugs are now being used(...)
Cancer Matters with Dr. Bill Nelson – Immunotherapy Before Surgery
Posted by | podcastDr Nelson talks with Dr Patrick Forde about his research showing the benefits of using immunotherapy treatments before surgery in lung cancer patients.
Patient Creates Award to Distinguish the Best Lung Cancer Doctors and Nurses
Posted by | UncategorizedKimmel Cancer Center team is among inaugural recipients (Photo: from left: Christine Hann, Russell Hales, Marilyn Holman, Matt Holman, Hanika Reyes Rodavia) Despite being a scientist, Matt Holman was unsure of the best treatment plan and where to go to find it when his wife Marilyn was diagnosed with small cell lung cancer in 2016. He(...)
Cancer Interception: Kimmel Experts Part of New Stand Up To Cancer Project
Posted by | Research, treatmentStand Up To Cancer launched four new teams aimed at detecting and treating cancer in its earliest stages. Lung cancer expert Julie Brahmer, M.D., is the lead investigator for Johns Hopkins for lung cancer studies based at the Kimmel Cancer Center Thoracic Center of Excellence she directs. Victor Velculescu, M.D., Ph.D., an expert in the(...)
Immunotherapy for Lung Cancer
Posted by | precision medicine, treatmentIt’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer for certain patients. Learn about the latest advances from our Bloomberg~Kimmel Institute for Cancer Immunotherapy and how we are helping patients with lung cancer live better and longer. Watch the(...)
Lung cancer immunotherapy options expand
Posted by | Issues & PerspectivesPatients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for all patients with non-small cell lung cancer, irrespective of patients’ tumor PD-L1 status. The new approval follows the FDA’s decision last November to approve pembrolizumab as a first-line therapy for some(...)
Do you have endocrinologists on the lung cancer team?
Posted by | treatmentEndocrinologists, or hormone doctors, are on your lung cancer treatment team “if it's clinically appropriate for them to be a part of it,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. Hales notes that “Endocrinologists often look at hormone levels, and we use(...)
What side effects can lung cancer radiation cause?
Posted by | treatmentMany lung cancer patients are concerned about the side effects lung cancer radiation can cause, such as heart or kidney damage, or fertility problems, says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus. “Any therapy can cause short-term or long-term problems, and side effects,”(...)
How does diet affect lung cancer risk or treatment? Do you have a nutritionist on my care team?
Posted by | Prevention/Screening, treatment“When I meet with patients, I tell them that there are three critical parts to their therapy. The first is local therapy, such as surgery or radiation. The second is chemotherapy, or systemic therapy. And the third is their overall well-being, such as nutrition,” says Russell K. Hales, M.D. Hales, a radiation oncologist at the(...)